158 related articles for article (PubMed ID: 2587017)
21. [Albumin eye drops for treatment of ocular surface diseases].
Unterlauft JD; Kohlhaas M; Hofbauer I; Kasper K; Geerling G
Ophthalmologe; 2009 Oct; 106(10):932-7. PubMed ID: 19813016
[TBL] [Abstract][Full Text] [Related]
22. [Corneal protection in contact lens users].
Egorova GB; Mitichkina TS; Shamsudinova AR
Vestn Oftalmol; 2014; 130(2):59-64, 66-7. PubMed ID: 24864502
[TBL] [Abstract][Full Text] [Related]
23. Autologous serum for ocular surface diseases.
Quinto GG; Campos M; Behrens A
Arq Bras Oftalmol; 2008; 71(6 Suppl):47-54. PubMed ID: 19274411
[TBL] [Abstract][Full Text] [Related]
24. Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone.
Zagon IS; Sassani JW; Immonen JA; McLaughlin PJ
Clin Exp Ophthalmol; 2014 Mar; 42(2):159-68. PubMed ID: 23777539
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of the effectiveness of Solcoseryl Eye-Gel in the treatment of various corneal diseases].
Gerkowicz K; Toczołowski J; Hamerski W; Jedrzejewski D; Gerkowicz M
Klin Oczna; 1985 Jan; 87(1):21-2. PubMed ID: 3900543
[No Abstract] [Full Text] [Related]
26. Changing the composition of buffered eye-drops prevents undesired side effects.
Schrage NF; Frentz M; Reim M
Br J Ophthalmol; 2010 Nov; 94(11):1519-22. PubMed ID: 20650912
[TBL] [Abstract][Full Text] [Related]
27. Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops.
Jee D; Park SH; Kim MS; Kim EC
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5081-9. PubMed ID: 24994869
[TBL] [Abstract][Full Text] [Related]
28. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy.
Yamada N; Matsuda R; Morishige N; Yanai R; Chikama TI; Nishida T; Ishimitsu T; Kamiya A
Br J Ophthalmol; 2008 Jul; 92(7):896-900. PubMed ID: 18511539
[TBL] [Abstract][Full Text] [Related]
29. Solcoseryl eye gel: an effective adjunct in the treatment of chronic ulcers of the cornea.
Bedavanija A; Singalavanija A; Kombara M
J Med Assoc Thai; 1985 Aug; 68(8):415-8. PubMed ID: 4067460
[No Abstract] [Full Text] [Related]
30. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
Salib GM; McDonald MB; Smolek M
J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of peptic ulcer with solcoseryl and etimizol].
Buliusin VIa; Shabanov PD; Sokolov LG
Sov Med; 1985; (12):116-7. PubMed ID: 3913004
[No Abstract] [Full Text] [Related]
32. Treatment of Sjögren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study.
Moscovici BK; Holzchuh R; Sakassegawa-Naves FE; Hoshino-Ruiz DR; Albers MB; Santo RM; Hida RY
Cont Lens Anterior Eye; 2015 Oct; 38(5):373-8. PubMed ID: 25956572
[TBL] [Abstract][Full Text] [Related]
33. Thymosin β4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trial.
Sosne G; Dunn SP; Kim C
Cornea; 2015 May; 34(5):491-6. PubMed ID: 25826322
[TBL] [Abstract][Full Text] [Related]
34. [Observations on the treatment of varicose and arterial ulcerations of legs with Solcoseryl (author's transl)].
Olejnicka Z
Ann Univ Mariae Curie Sklodowska Med; 1979; 34():317-21. PubMed ID: 400434
[No Abstract] [Full Text] [Related]
35. Comparison of autologous serum eye drops with different diluents.
Cho YK; Huang W; Kim GY; Lim BS
Curr Eye Res; 2013 Jan; 38(1):9-17. PubMed ID: 22928476
[TBL] [Abstract][Full Text] [Related]
36. Clinical evaluation of corneal epithelialization after photorefractive keratectomy in patients treated with polydeoxyribonucleotide (PDRN) eye drops: a randomized, double-blind, placebo-controlled trial.
Lazzarotto M; Tomasello EM; Caporossi A
Eur J Ophthalmol; 2004; 14(4):284-9. PubMed ID: 15309972
[TBL] [Abstract][Full Text] [Related]
37. Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study.
Tauber J; Karpecki P; Latkany R; Luchs J; Martel J; Sall K; Raychaudhuri A; Smith V; Semba CP;
Ophthalmology; 2015 Dec; 122(12):2423-31. PubMed ID: 26365210
[TBL] [Abstract][Full Text] [Related]
38. Histological evaluation of wound healing in horses treated with the protein-free hemodialysate Solcoseryl and its hexosylceramide fraction.
Liebich HG; Hamm D; Jöchle W
Zentralbl Veterinarmed B; 1988 Feb; 35(2):84-95. PubMed ID: 3420985
[No Abstract] [Full Text] [Related]
39. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.
Yoon KC; Heo H; Im SK; You IC; Kim YH; Park YG
Am J Ophthalmol; 2007 Jul; 144(1):86-92. PubMed ID: 17493572
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of treatment for dry eye with 2-hydroxyestradiol using a dry eye rat model.
Higuchi A; Oonishi E; Kawakita T; Tsubota K
Mol Vis; 2016; 22():446-53. PubMed ID: 27186071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
